tradingkey.logo

Outset Medical Inc

OM

14.600USD

-0.440-2.93%
Horarios del mercado ETCotizaciones retrasadas 15 min
258.74MCap. mercado
PérdidaP/E TTM

Outset Medical Inc

14.600

-0.440-2.93%
Más Datos de Outset Medical Inc Compañía
Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Información de la empresa
Símbolo de cotizaciónOM
Nombre de la empresaOutset Medical Inc
Fecha de salida a bolsaSep 15, 2020
Director ejecutivoMs. Leslie L. Trigg
Número de empleados354
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 15
Dirección3052 Orchard Drive
CiudadSAN JOSE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal95134
Teléfono16692318200
Sitio Webhttps://outsetmedical.com/
Símbolo de cotizaciónOM
Fecha de salida a bolsaSep 15, 2020
Director ejecutivoMs. Leslie L. Trigg
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
69.22K
+1580.17%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
35.25K
+532.30%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
9.22K
+3711.98%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
Mr. John L. Brottem
Mr. John L. Brottem
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. D. Keith Grossman
Mr. D. Keith Grossman
Lead Independent Director
Lead Independent Director
--
--
Ms. Andrea L. Saia
Ms. Andrea L. Saia
Independent Director
Independent Director
--
--
Ms. Renee M. Gaeta, CPA
Ms. Renee M. Gaeta, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
69.22K
+1580.17%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
35.25K
+532.30%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
9.22K
+3711.98%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
14.20M
47.74%
Services and other revenue
8.46M
28.43%
Consoles
7.09M
23.83%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
14.20M
47.74%
Services and other revenue
8.46M
28.43%
Consoles
7.09M
23.83%
Estadísticas de accionistas
Actualizado: sáb., 14 de jun
Actualizado: sáb., 14 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
14.55%
Durable Capital Partners LP
9.82%
Alyeska Investment Group, L.P.
9.61%
PFM Health Sciences, LP
9.51%
T. Rowe Price Investment Management, Inc.
9.05%
Other
47.47%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
14.55%
Durable Capital Partners LP
9.82%
Alyeska Investment Group, L.P.
9.61%
PFM Health Sciences, LP
9.51%
T. Rowe Price Investment Management, Inc.
9.05%
Other
47.47%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
40.58%
Investment Advisor
31.55%
Investment Advisor/Hedge Fund
9.99%
Private Equity
4.70%
Individual Investor
2.08%
Venture Capital
0.94%
Corporation
0.63%
Research Firm
0.28%
Bank and Trust
0.12%
Other
9.13%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
347
16.11M
90.89%
+12.67M
2025Q1
363
14.91M
84.25%
+11.40M
2024Q4
375
22.97M
42.67%
-34.22M
2024Q3
383
28.58M
54.40%
-41.22M
2024Q2
397
50.60M
97.17%
-19.65M
2024Q1
406
52.26M
101.52%
-18.15M
2023Q4
416
54.21M
107.73%
-7.17M
2023Q3
407
56.98M
114.62%
-11.76M
2023Q2
399
56.04M
113.10%
-11.31M
2023Q1
408
55.02M
111.94%
-9.31M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
2.58M
14.55%
+2.35M
+1040.39%
Mar 31, 2025
Durable Capital Partners LP
1.74M
9.82%
+1.74M
--
Mar 31, 2025
Alyeska Investment Group, L.P.
1.70M
9.61%
+1.70M
--
Mar 31, 2025
PFM Health Sciences, LP
1.69M
9.51%
+1.69M
--
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.60M
9.05%
+1.39M
+659.32%
Mar 31, 2025
Woodline Partners LP
1.33M
7.48%
+1.33M
--
Mar 31, 2025
The Vanguard Group, Inc.
173.32K
0.98%
-602.00
-0.35%
Mar 31, 2025
MFS Investment Management
840.25K
4.74%
+840.25K
--
Mar 31, 2025
Perceptive Advisors LLC
833.33K
4.7%
+833.33K
--
Mar 31, 2025
Marshall Wace LLP
650.26K
3.67%
+650.26K
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Value ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
SPDR S&P Health Care Equipment ETF
0%
Ver más
iShares Micro-Cap ETF
Proporción0.06%
iShares Russell 2000 Value ETF
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
Avantis US Small Cap Equity ETF
Proporción0.01%
SPDR S&P Health Care Equipment ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Fecha
Tipo
Relación
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
KeyAI